221 related articles for article (PubMed ID: 17409018)
1. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. Amantadine therapy in renal transplant patients with hepatitis C virus infection.
Kamar N; Rostaing L; Sandres-Saune K; Ribes D; Durand D; Izopet J
J Clin Virol; 2004 May; 30(1):110-4. PubMed ID: 15072764
[TBL] [Abstract][Full Text] [Related]
4. Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.
Brillanti S; Levantesi F; Masi L; Foli M; Bolondi L
Hepatology; 2000 Sep; 32(3):630-4. PubMed ID: 10960460
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
6. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
Jain AB; Eghtesad B; Venkataramanan R; Fontes PA; Kashyap R; Dvorchik I; Shakil AO; Kingery L; Fung JJ
Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
[TBL] [Abstract][Full Text] [Related]
8. A monocentric observational study of darbepoetin alfa in anemic hepatitis-C-virus transplant patients treated with ribavirin.
Kamar N; Guitard J; Ribes D; Esposito L; Rostaing L
Exp Clin Transplant; 2008 Dec; 6(4):271-5. PubMed ID: 19338488
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
Honda T; Katano Y; Urano F; Murayama M; Hayashi K; Ishigami M; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
J Gastroenterol Hepatol; 2007 Jul; 22(7):989-95. PubMed ID: 17608843
[TBL] [Abstract][Full Text] [Related]
11. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
Nephrologie; 2003; 24(2):89-94. PubMed ID: 12723514
[TBL] [Abstract][Full Text] [Related]
12. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
[TBL] [Abstract][Full Text] [Related]
13. Role of amantadine and other adjuvant therapies in the treatment of hepatitis C.
Brillanti S
Semin Liver Dis; 2004; 24 Suppl 2():89-95. PubMed ID: 15346251
[TBL] [Abstract][Full Text] [Related]
14. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
Terrault NA; Adey DB
Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.
Di Martino V; Boudjema H; Delacour T; Cazier A; Caron C; Coutarel P; Dumouchel P; Cadranel JF
Clin Infect Dis; 2001 Mar; 32(5):830-1. PubMed ID: 11229855
[TBL] [Abstract][Full Text] [Related]
16. Treatment of HCV in patients with renal failure.
Kalia H; Lopez PM; Martin P
Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
18. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
Kamar N; Boulestin A; Selves J; Esposito L; Sandres-Saune K; Stébenet M; Chatelut E; Durand D; Rostaing L; Izopet J
J Med Virol; 2005 May; 76(1):61-8. PubMed ID: 15778976
[TBL] [Abstract][Full Text] [Related]
19. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
[TBL] [Abstract][Full Text] [Related]
20. Amantadine in the treatment of patients with chronic hepatitis C.
Foster GR
Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):614-5. PubMed ID: 10076784
[No Abstract] [Full Text] [Related]
[Next] [New Search]